“Life, love, and purpose are threads of the same cloth — we’re just learning how to weave them.”
One minute you’re minding your own business, enjoying a muffin and growing a whole human… and the next? Your midwife is talking about blood sugar tests, carb balancing, and the word “diabetes” gets thrown around like it’s a personal failing.
Let me stop you right there:
Gestational diabetes is not your fault.
Your body isn’t broken — it’s doing something incredible, and just like any massive construction project, things can get a little chaotic behind the scenes.
Let’s talk about what’s really going on.
Gestational Diabetes Mellitus (GDM) happens when the hormones from the placenta — those magical, powerful, life-giving hormones — start interfering with how your body uses insulin.
Here’s a super simple breakdown:
Your pancreas makes insulin (think of insulin as the key that unlocks your cells so glucose can go in and give you energy).
In pregnancy, your placenta starts producing hormones that block that insulin from working efficiently.
That’s great for the baby (they get more glucose!) — but not so great for you. Your blood sugar can build up like a traffic jam with no exit ramp.
💥 Boom: You’ve got insulin resistance.
If your pancreas can’t keep up with the increased demand, blood sugar levels rise, and that’s what we call gestational diabetes.
It’s a great question—and a valid frustration. GDM isn’t just about food. It’s about how your unique body handles the metabolic wild ride of pregnancy.
Factors that play a role:
Genetics (yes, family history matters)
Hormonal shifts
How your body processes carbs and sugar
Previous pregnancies
Stress levels and sleep (really!)
From the Midwife’s Chair:
I once had a client who sobbed in my office after being diagnosed. “I only eat homemade food! I don’t even like soda!” she cried.
And she wasn’t wrong.
Her diagnosis wasn’t about willpower. It was about physiology. And once she understood what her body was doing, she took back the reins with power and grace.
Most people find out they have GDM during the second trimester glucose screening (around 24–28 weeks).
Common testing includes:
Glucose challenge (50g drink, then a blood draw an hour later)
Glucose tolerance test (more intense version if needed)
Finger stick blood sugar monitoring at home
Treatment may involve:
Diet changes (more protein + fiber, strategic carbs)
Gentle movement after meals
Stress reduction and good sleep
Sometimes, medication or insulin if needed
Ina May Gaskin reminds us that our bodies are wise—but that birth wisdom and modern medicine can walk together.
Lily Nichols, RDN has a stellar book: Real Food for Gestational Diabetes, packed with recipes, blood sugar-friendly swaps, and real science.
Elizabeth Davis in Heart & Hands emphasizes nutrition as a key pillar of physiological birth and whole-person wellness.
So many birthing people walk away from a GDM diagnosis feeling like they failed.
Let me say this clearly:
You didn’t fail. You adapted.
Your body just needs a little support while it does the impossible: growing life.
Book a virtual birth coaching session and we’ll walk through your diagnosis together — from food plans to emotional support.
Your voice matters—especially when it’s shaking.
Keep showing up. Keep asking. And know that you’re already doing an incredible job.
🖋️ —The Manistee Midwife
For decades, the "ghost" of Emanuel Friedman has haunted the delivery room, with a ticking clock often dictating the pace of human birth. Expectant parents frequently enter labor bracing for a high-stakes waiting game, unaware that the benchmarks for "normal" progress—and the technology used to monitor it—are undergoing a radical evidence-based overhaul. While medical technology has advanced, contemporary data reveals that some of our most deeply held obstetric habits may actually hinder the very outcomes they aim to protect.
The goal of this inquiry is to bridge the gap between institutional habit and modern clinical reality, distilling high-impact takeaways that empower both parents and practitioners to prioritize "normality" through shared decision-making.
Historically, the "Friedman Curve" suggested that active labor—the phase where dilation accelerates—began at a mere 3 to 4 centimeters. Under this rigid timeline, any deviation often led to a premature diagnosis of "failure to progress." Today, the contemporary Zhang framework has shattered this clock.
We now recognize that active labor does not truly ignite until 6 centimeters. Before this threshold, the "latent phase" can last for hours without cervical change—a reality that is perfectly normal and does not warrant surgical intervention. Current guidelines from ACOG and the evidence-based modules suggest that if maternal and fetal status remains reassuring, practitioners should wait at least four hours without cervical change before escalating. By acknowledging that labor is non-linear and accelerates later, we can effectively mitigate the "IUPC irony" (see Reality 5) and reduce unnecessary Cesareans.
Quick Stats
Old Standard (Friedman): Active labor begins at 3–4 cm.
New Standard (Zhang): Active labor begins at 6 cm.
Clinical Impact: Waiting up to 4 hours without cervical change is often normal before intervention, provided status is reassuring.
Continuous cardiotocography (CTG)—the electronic monitoring of fetal heart rates—is the hospital standard, yet it presents a profound medical paradox. A landmark Cochrane Review has revealed a difficult trade-off: while continuous CTG halves the rate of neonatal seizures, it does not significantly reduce rates of cerebral palsy or perinatal mortality. This is partly because intrapartum asphyxia is not a common cause of cerebral palsy; most cases are linked to antepartum infection or preterm birth.
The clinical cost of this data is high. According to the Cochrane source:
"Continuous CTG was associated with an increase in caesarean sections and instrumental vaginal births. The challenge is how best to convey these results to women to enable them to make an informed decision without compromising the normality of labour."
Beyond the surgery rates, the "machine-focus" creates a shift in staff resources. Instead of the one-to-one support found in successful protocols like the Dublin model, staff focus often turns toward "constantly interpreting the CTG" rather than the woman. This shift, combined with the decreased mobility mandated by cords and belts, can inadvertently stall labor progress.
The traditional supine (lying on back) position persists largely for the convenience of the monitor and the provider, despite evidence that it restricts the pelvis's natural plasticity and forces the fetus to descend against gravity.
Critically, new research—such as the 2021 Guangzhou study—has debunked the myth that movement is only for "unmedicated" births. Upright movement is effective and safe even for women who have received intraspinal labor analgesia (epidurals). By utilizing standing, squatting, or a delivery ball, the birth axis aligns with the fetal axis, using gravity to descend the head and induce reflex contractions.
Evidence-based activity management programs report:
Shortened Labor Time: Significant reductions across the first, second, and third stages.
Reduced Complications: Lower incidences of postpartum hemorrhage and fetal distress.
Improved Recovery: Significantly lower rates of pelvic organ prolapse (POP) and pelvic floor dysfunction 42 days postpartum.
Misoprostol (Cytotec) is a staple for labor induction, yet its "off-label" status creates a pharmaceutical gray area. Pfizer’s "Black Box" warning is explicit: the drug is intended for gastric ulcers and can cause birth defects, abortion, or uterine rupture in pregnant women.
This creates a mystery for parents: why use it? The reality is political and financial. Because Misoprostol is a low-cost generic, manufacturers have zero incentive to fund the expensive FDA approval process for obstetrics. Furthermore, because it is used for medical abortion, it remains a political target. Clinically, while effective, it must be handled with extreme care. The risk of uterine rupture is not only tied to prior Cesarean sections but also increases with grand multiparity. In these cases, the drug is strictly contraindicated.
When labor "slows" according to the old Friedman clock, providers often suggest an Intrauterine Pressure Catheter (IUPC) to measure the strength of contractions in Montevideo Units (MVUs). The goal is to reach a threshold of 200–250 MVUs to prove "adequate labor."
Here lies the irony: ACOG provides a "strong recommendation" for IUPC use in protracted labor, yet simultaneously admits this is based on "low-quality evidence." Systematic reviews show that IUPCs do not improve maternal or neonatal outcomes—such as Apgar scores or NICU admissions—when compared to manual palpation by an experienced examiner. Palpation is a hallmark midwifery skill that determines labor adequacy without the cost, complexity, and invasive nature of an internal catheter.
The path to a safer, more respectful birth culture lies in the transition from "institutional habit" to "evidence-based reality." When we embrace the 6-centimeter shift, we reduce the pressure for invasive IUPCs; when we prioritize movement—even with an epidural—we align with the body’s physiology rather than fighting it.
Shared decision-making requires us to look past the monitors and back to the person in the bed. Turning the tide requires us to account for the "Hawthorne Effect"—the knowledge that how we observe labor changes the labor itself. If the data shows that less technology and more movement often lead to safer outcomes, why is our birth culture still so anchored to the bed and the monitor?